Overview in PsyPost To view or add a comment, sign in Boehringer Ingelheim has announced positive Phase II results for its TRPC6 inhibitor in patients with focal segmental glomerulosclerosis (FSGS), showing both efficacy and good tolerability
Great comments on the 6 benefits of GLP-1s beyond weight loss
Emails were answered quickly
Since self-reported data is highly subjective and noisy, we enforced strict cohort selection
If pricing, policies, or claims are hard to find or understand, thats a problem, so we make sure everything is on the up and up: Clarity and accessibility of pricing and policies Accuracy and authenticity of images and representations Directness and completeness of answers to patient questions Use of credible sources and verifiable links Honesty and restraint in marketing and sales practices Clear Pricing and Policies Pricing and policies should be obvious, up-front, and consistent from website to checkout
Add 100 ul of TMB One-Step Substrate Reagent to each well